Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0 USD 0.00(0%)
Last update at 2026-11-17T21:00:00Z
VOLUME
300000
Market Cap
0.82M

Momentum Score

…

Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
-
Low
-
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-1.40
ROE
-
Net Debt
19.40M
ROCE
-153.99%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Income before tax - -6.63M -1.88M - -
Net income - -6.63M -1.89M - -
Gross profit - -3.08M -1.06M - -
Ebit - -4.13M -1.83M -0.60M -0.57M
Ebitda - -4.01M -1.57M - -
Depreciation and amortization 0.17M 0.12M 0.26M - -
Operating income - -8.47M -1.83M - -
Other operating expenses - 11.31M 3.59M - -
Interest expense - 0.46M 0.05M 0.00M 0.00M
Income tax expense - - 0.00M - -
Total revenue - 2.85M 1.76M - -
Total operating expenses - 5.39M 0.78M - -
Cost of revenue - 5.92M 2.82M - -
Total other income expense net - 1.84M -0.05M - -
Net income applicable to common shares - - - -0.95M -2.24M
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Total assets - 18.03M 16.55M - -
Other current assets - 0.11M 0.01M - -
Total liab - 28.59M 19.34M - -
Total stockholder equity - -10.55M -2.79M - -
Other current liab - 8.31M -0.01M 2.03M 1.57M
Common stock - 1.40M - 4.12M 2.16M
Retained earnings - -9.50M -2.87M -12.37M -11.42M
Other assets - 0.00M - - -
Cash - 0.34M 0.33M - -
Total current liabilities - 15.35M 5.87M 7.08M 6.39M
Net debt - 19.40M 14.77M - -
Short term debt - 5.68M 5.87M - -
Short long term debt total - 14.82M 15.11M - -
Other stockholder equity - -11.58M 0.08M - -
Total current assets - 2.74M 1.54M 0.03M 0.03M
Net tangible assets - - - -7.06M -6.36M
Net receivables - 1.15M 0.18M - -
Inventory - 1.14M 1.01M - -
Accounts payable - 1.37M 0.02M 0.55M 0.53M
Accumulated other comprehensive income - -1.40M - - -
Non currrent assets other - -0.00M - - -
Non current assets total - 15.30M 15.01M - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Change to liabilities - - - 0.24M 0.16M
Total cashflows from investing activities - 2.97M -0.43M - -
Net borrowings - - - 0.02M 0.17M
Total cash from financing activities - 1.56M 2.45M 0.57M 0.17M
Change to operating activities - - - - 0.05M
Net income - -4.59M -1.89M -0.95M -2.24M
Change in cash - 0.01M 0.33M 0.00M 0.00M
Begin period cash flow 0.34M 0.33M 0.00M - 0.09M
End period cash flow 0.34M 0.34M 0.33M - -
Total cash from operating activities - -4.52M -1.92M -0.57M -0.17M
Depreciation - 0.12M 0.26M - -
Other cashflows from investing activities - 3.24M - - -
Change to inventory - -0.84M -0.75M - 0.03M
Change to account receivables - -0.97M -0.18M - -
Other cashflows from financing activities - 2.97M 2.02M - -
Change to netincome - - - 0.13M 1.78M
Capital expenditures 0.00M 0.27M 0.43M 0.00M 0.00M
Change in working capital - -1.09M -0.29M - -
Other non cash items - 1.04M 0.00M - -
Free cash flow - -5.95M -2.35M - -

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR
-0.23
0.70%
32.85 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
169.42 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
-
-%
21.27 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-0.54
1.24%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

Nutranomics Inc

Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.

11487 South 700 East, Salt Lake City, UT, United States, 84020

801-576-8350

1

Name Title Year Born
Mr. Jonathan Bishop CEO & Member of Advisory Board NA
Mr. Geoffrey Bazegian Pres & Chief Revenue Officer NA
Ms. Laura Riffel Chief Operations Officer NA
Mr. Neil Zoller Sr. VP of Agricultural Supply Chain NA
Dr. Edward J. Eyring II, M.D. Gen. Mang. 1967
Mr. Geoffrey Bazegian President & Chief Revenue Officer NA
Mr. Neil Zoller Senior Vice President of Agricultural Supply Chain NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…